Skip to main content
1-featuredimage

Welcome to hubXchange's Advanced Therapies Xchange New Jersey 2026. 

This event brings together senior-level scientists and executives from the pharmaceutical and biotech sectors to tackle key challenges in Next Gen Vector Engineering & Delivery,  Cell Therapy Development Gene Therapy Development , Cell Therapy Manufacturing.Gene Therapy Manufacturing

Attendees can engage in roundtable discussions, pre-booked 1:1 meetings, presentations, and networking sessions with top industry experts, to foster collaboration and find innovative solutions to accelerate advanced therapies.

New Jersey | Wednesday 4th November 2026  | 08:00am - 18:15pm

VIEW AGENDA    REGISTER NOW    OUR PARTNERS    EVENT INFORMATION

Why choose hubXchange?

FULL AGENDA

Click the topic titles to find out more!

Loading
08:00
  1. Registration
    30 mins
    • Next Gen Vector Engineering & Delivery
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
08:30
  1. Opening Address & Keynote Presentation
    30 mins
    • Next Gen Vector Engineering & Delivery
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
09:05
  1. Cell Therapy Development
    60 mins
    • Cell Therapy Development
    FDA's new CAR-T CMC guidance and the Potency Assurance draft both push the burden back onto sponsors to justify their analytical strategy from first principles. Is the field actually ready for that, o ...
  2. Cell Therapy Manufacturing
    60 mins
    • Cell Therapy Manufacturing
    The Future of Ex Vivo Manufacturing: Evolution or Extinction With advances in in vivo CAR engineering, allogeneic platforms, and gene delivery technologies, are we witnessing the beginning of the end ...
  3. Gene Therapy Development
    60 mins
    • Gene Therapy Development
    Which AAV analytical assays can be performed at low scale and with little to no purification early in the process of optimizing a new system? Which have you found to be most valuable? Purification by ...
  4. Gene Therapy Manufacturing
    60 mins
    • Gene Therapy Manufacturing
    • How can process control strategies and release/shelf‑life specifications be appropriately established when CMC timelines are compressed and early data come from limited clinical batches?

    • In what ways can Quality‑by‑Design (QbD) principles be applied to gene therapy CMC development to reduce long‑term lifecycle management burden?

    • Beyond the typical CQAs (genome titer, total particle number, infectivity, potency, aggregation, and particle composition), are there additional attributes that should be characterised for gene therapy products?

    • How should analytical methods for CQA testing be upgraded or expanded throughout product lifecycle management, given evolving platforms and limited industry standardisation?

    • What real‑world experiences demonstrate how automation improves consistency, reduces variability, and strengthens compliance in gene therapy manufacturing?

    • What examples exist of data modelling, AI, or digital‑twin technologies being applied to gene therapy manufacturing processes?

10:10
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Next Gen Vector Engineering & Delivery
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
10:40
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Next Gen Vector Engineering & Delivery
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
11:10
  1. Morning Refreshments
    10 mins
    • Next Gen Vector Engineering & Delivery
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
12:20
  1. Networking Lunch
    60 mins
    • Next Gen Vector Engineering & Delivery
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
13:25
  1. Spotlight Presentation
    30 mins
    • Next Gen Vector Engineering & Delivery
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
14:00
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Next Gen Vector Engineering & Delivery
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
14:30
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Next Gen Vector Engineering & Delivery
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
15:35
  1. Afternoon Refreshments
    10 mins
    • Next Gen Vector Engineering & Delivery
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
15:45
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Next Gen Vector Engineering & Delivery
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing
17:50
  1. Evening Drinks Reception
    60 mins
    • Next Gen Vector Engineering & Delivery
    • Cell Therapy Development
    • Cell Therapy Manufacturing
    • Gene Therapy Development
    • Gene Therapy Manufacturing

EVENT INFORMATION

3-featuredimage

DATES

New Jersey
4 November 2026
Wednesday 4th May 2026

 

DoubleTree Princeton Hotel

VENUE

Hilton Munich Airport Hotel

DoubleTree by Hilton Hotel Princeton
4355 US Route 1
Princeton, New Jersey 08540
United States

MAP

EVENT PARNTERS

4-featuredimage

REGISTRATION FORM - Register for free!

6-featuredimage

Complimentary Registration is only available for Senior Scientists & above, in Pharma & Bio Tech, with an active drug pipeline.

 

For Service Providers, please click here.